Our finding that neutrophils highly and preferentially express CXCR2 in both periphery and TME in tumor-bearing mice provides a mechanistic insight on the exclusive blocking effect of the CXCR2 antagonist on neutrophils. This evidence concerns the gene CXCR2 and neoplasm.